🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 10 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
03/01/2018 21,14 21,55 20,72 21,02 -0,61% 3,93% 97.300
02/01/2018 21,05 21,68 20,62 21,15 +1,68% 5,04% 146.900
29/12/2017 20,63 21,31 20,29 20,80 +1,81% 4,94% 110.800
28/12/2017 20,53 20,76 20,24 20,43 +0,15% 2,53% 47.500
27/12/2017 20,43 20,56 19,80 20,40 +0,44% 3,72% 79.400
26/12/2017 20,23 20,68 19,26 20,31 +4,15% 7,02% 139.200
22/12/2017 19,15 20,78 19,15 19,50 -0,26% 8,51% 120.200
21/12/2017 19,28 19,77 19,28 19,55 +1,03% 2,54% 96.600
20/12/2017 19,70 19,81 19,00 19,35 -1,48% 4,13% 56.100
19/12/2017 19,99 20,09 19,31 19,64 -1,26% 3,90% 141.800
18/12/2017 19,38 20,12 19,34 19,89 +4,74% 4,02% 140.200
15/12/2017 18,29 19,45 18,29 18,99 +4,17% 6,36% 292.400
14/12/2017 18,30 18,70 18,03 18,23 +0,39% 3,69% 83.100
13/12/2017 17,65 18,72 17,65 18,16 +3,36% 6,06% 195.800
12/12/2017 18,32 18,61 17,41 17,57 -3,78% 6,55% 86.700
11/12/2017 18,73 18,87 18,06 18,26 -1,14% 4,32% 83.200
08/12/2017 19,28 19,28 18,30 18,47 -4,30% 5,08% 58.100
07/12/2017 18,47 19,82 18,47 19,30 +5,06% 7,31% 58.600
06/12/2017 18,47 18,70 17,75 18,37 -0,11% 5,14% 38.400
05/12/2017 17,50 18,85 17,50 18,39 +4,07% 7,71% 110.000
04/12/2017 19,06 19,49 17,60 17,67 -8,21% 9,89% 71.700
01/12/2017 19,50 19,60 18,42 19,25 -1,28% 6,05% 95.700
30/11/2017 19,17 20,43 18,65 19,50 +1,51% 9,29% 136.200
29/11/2017 18,89 19,45 18,82 19,21 +0,31% 3,34% 48.400
28/11/2017 19,28 19,57 18,91 19,15 -0,83% 3,42% 58.600
27/11/2017 19,45 19,63 16,70 19,31 -1,48% 15,06% 30.600
24/11/2017 19,33 19,77 19,16 19,60 -0,05% 3,16% 25.800
22/11/2017 19,20 19,79 19,15 19,61 +2,72% 3,34% 89.000
21/11/2017 18,83 19,24 18,52 19,09 +2,86% 3,82% 71.200
20/11/2017 17,45 18,84 17,19 18,56 +6,67% 9,43% 163.000